Cloning of mouse mitochondrial thymidine kinase 2 cDNA

K Wettin1, M Johansson, X Zheng

  • 1Division of Clinical Virology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.

FEBS Letters
|November 26, 1999
PubMed

Insights

Mitochondrial thymidine kinase 2 (TK2) activates antiviral drugs, potentially causing toxicity. Researchers cloned mouse TK2, confirming its mitochondrial targeting, aiding the study of drug activation and toxicity mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Mitochondrial toxicity is a concern with antiviral nucleoside analogs.
  • Mitochondrial thymidine kinase 2 (TK2) is suspected to play a role in this toxicity through drug phosphorylation.

Purpose of the Study:

  • To clone the cDNA of mouse mitochondrial thymidine kinase 2 (TK2).
  • To confirm the mitochondrial localization of TK2.
  • To provide a tool for understanding TK2's role in nucleoside analog activation.

Main Methods:

  • Cloning of mouse TK2 cDNA.
  • Expression of TK2 fused to green fluorescent protein (GFP) in cells.
  • Confocal microscopy to verify mitochondrial localization of the TK2-GFP fusion protein.

Main Results:

  • Successfully cloned the cDNA sequence for mouse TK2.
  • Demonstrated that expressed TK2 is targeted to the mitochondria.
  • Established the first cloned mitochondrial TK2 for further research.

Conclusions:

  • The cloning of mouse TK2 provides a crucial resource for studying its function.
  • This work facilitates research into the mechanisms of mitochondrial toxicity induced by antiviral nucleoside analogs.
  • Understanding TK2's role is key to developing safer and more effective antiviral therapies.